These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37202560)

  • 21. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma.
    Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y
    Front Immunol; 2022; 13():992990. PubMed ID: 36311764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
    Wang X; Duanmu J; Fu X; Li T; Jiang Q
    J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
    Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
    Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
    [No Abstract]   [Full Text] [Related]  

  • 24. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
    Mjelle R; Sjursen W; Thommesen L; Sætrom P; Hofsli E
    BMC Cancer; 2019 Feb; 19(1):161. PubMed ID: 30786859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 13-Immune Gene Set Signature for Prediction of Colon Cancer Prognosis.
    Lu Z; Chen J; Yan J; Liu Q; Li F; Xiong W; Lin S; Yu K; Liang J
    Comb Chem High Throughput Screen; 2021; 24(8):1205-1216. PubMed ID: 32998675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.
    Wang Y; Lin K; Xu T; Wang L; Fu L; Zhang G; Ai J; Jiao Y; Zhu R; Han X; Cai H
    Aging (Albany NY); 2021 Jul; 13(14):19028-19047. PubMed ID: 34315829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
    Chen YJ; Guo X; Liu ML; Yu YY; Cui YH; Shen XZ; Liu TS; Liang L
    Front Immunol; 2022; 13():979521. PubMed ID: 36569910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
    Ge W; Hu H; Cai W; Xu J; Hu W; Weng X; Qin X; Huang Y; Han W; Hu Y; Yu J; Zhang W; Ye S; Qi L; Huang P; Chen L; Ding K; Wang LD; Zheng S
    Int J Cancer; 2020 Apr; 146(7):2027-2035. PubMed ID: 31693169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic and genomic profiling of multiple primary colorectal cancers reveals intratumor heterogeneity and a distinct immune microenvironment.
    Li Y; Li C; Wang Q; Ye YJ; Jiang KW
    Int Immunopharmacol; 2024 Jan; 126():111276. PubMed ID: 38016348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.
    Demirkol Canlı S; Seza EG; Sheraj I; Gömçeli I; Turhan N; Carberry S; Prehn JHM; Güre AO; Banerjee S
    Carcinogenesis; 2020 Sep; 41(9):1219-1228. PubMed ID: 32628753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of m6A-related lncRNAs as prognostic signature within colon tumor immune microenvironment.
    Cao L; Zhang S; Ba Y; Zhang H
    Cancer Rep (Hoboken); 2023 Jun; 6(6):e1828. PubMed ID: 37178411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.